NEW YORK and TOKYO, May 21, 2025 /PRNewswire/ — TNL Mediagene (Nasdaq: TNMG) (the “Company”), a Tokyo-based next-generation digital media and data group in Asia, announces its recent feature interview on McNallie Money.

Co-Founder & CEO Joey Chung joins host Bryce McNallie to discuss the Company’s recently announced strong FY2024 performance of consolidated revenue of $48.5million, gross profit of $17.7million, near break-even Adjusted EBITDA and Adjusted EPS of negative $0.035 per share, launch of Business Insider Taiwan* in 2025, focus on acquisitive growth through M&A and the AI-based multilingualization strategy the Company is using to expand its content reach into new markets.

*The name “Business Insider Taiwan” used in this release is a provisional designation for convenience. The official name will be determined at a later date.

Financial Data

The condensed financial information presented in this press release should be read in conjunction with the audited consolidated financial statements and related notes for the year ended December 31, 2024 included in TNL Mediagene’s annual report on Form 20-F filed with the SEC on April 30, 2025, which provides a more complete discussion of its accounting policies and certain other information.

Use and Reconciliation of Non-IFRS Financial Measures

In this press release, we have included adjusted EBITDA, a non-IFRS financial measure, and adjusted EPS, a non-IFRS measure, which are key measures used by our management and board of directors in evaluating our operating performance.

Adjusted EBITDA and adjusted EPS are our preferred metrics for profitability because we believe they facilitate operating performance and profit performance comparisons on a period-to-period basis and exclude items that we do not consider to be indicative of our core operating performance.

Adjusted EBITDA and adjusted EPS have limitations as analytical tools, and you should not consider it in isolation or as a substitute for analysis of our results as reported under IFRS. Some of these limitations are:

although amortization and depreciation are non-cash charges, the assets being amortized and depreciated may have to be replaced in the future, and adjusted EBITDA and adjusted EPS do not reflect cash capital expenditure requirements for such replacements or for new capital expenditure requirements;adjusted EBITDA and adjusted EPS do not reflect changes in, or cash requirements for, our working capital needs;adjusted EBITDA and adjusted EPS do not reflect the potentially dilutive impact of equity-based compensation; andother companies, including our competitors in various industries, may calculate adjusted EBITDA and adjusted EPS or similarly titled measures differently, which reduces its usefulness as a comparative measure.

We define adjusted EBITDA as profit (loss) for the period excluding (i) non-cash items such as depreciation expenses, amortization expenses, stock-based compensation expenses and impairment loss on intangible assets and (ii) extraordinary items associated with one-time events and transactions, such as one-time transaction-related expenses not eligible for capitalization.

We define adjusted EPS as profit (loss) for the period excluding (i) non-cash items such as depreciation expenses, amortization expenses, stock-based compensation expenses and impairment loss on intangible assets and (ii) extraordinary items associated with one-time events and transactions, such as one-time transaction-related expenses not eligible for capitalization, extraordinary finance costs and related commitment fees.

Our management does not consider adjusted EBITDA or adjusted EPS in isolation or as an alternative to financial measures determined in accordance with IFRS. The principal limitation of adjusted EBITDA and adjusted EPS is that they exclude significant expenses that are required by IFRS to be recorded in TNL Mediagene’s financial statements. In addition, adjusted EBITDA and adjusted EPS are subject to inherent limitations as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining such non-IFRS financial measures.

For more details on the definitions of adjusted EBITDA and adjusted EPS and reconciliations of adjusted EBITDA and adjusted EPS to IFRS financial measures, see the press release and the investor presentation TNL Mediagene released on May 13, 2025.

About TNL Mediagene

Headquartered in Tokyo, TNL Mediagene was formed in May 2023 through the merger of Taiwan’s The News Lens Co. and Japan’s Mediagene Inc., two of the region’s leading independent digital media groups. The company’s operations span original and licensed media brands in Japanese, Chinese, and English, covering topics such as news, business, technology, science, food, sports, and lifestyle. It also offers AI-driven advertising services, marketing technology platforms, e-commerce, and innovative solutions tailored to the needs of advertising agencies. Known for its political neutrality, appeal to younger audiences, and high-quality content, TNL Mediagene has approximately 500 employees across Asia, with offices in Japan, Taiwan, and Hong Kong.

https://www.tnlmediagene.com/

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are based on beliefs and assumptions and on information currently available to TNL Mediagene. Forward-looking statements generally relate to future events or TNL Mediagene’s future financial or operating performance. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” “target,” “seek” or the negative or plural of these words, or other similar expressions that are predictions or indicate future events or prospects, although not all forward-looking statements contain these words. Forward-looking statements in this communication include, but are not limited to, statements in the section entitled “2025 Initiatives and Outlook” and “Management Commentary” such as statements about TNL Mediagene’s future business plan and growth strategies and statements by TNL Mediagene’s CEO and president. Any statements that refer to expectations, projections or other characterizations of future events or circumstances, including strategies or plans, are also forward-looking statements. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by these forward-looking statements. Forward-looking statements in this communication or elsewhere speak only as of the date made. New uncertainties and risks arise from time to time, and it is impossible for TNL Mediagene to predict these events or how they may affect TNL Mediagene. In addition, risks and uncertainties are described in TNL Mediagene’s filings with the Securities and Exchange Commission. These filings may identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. TNL Mediagene cannot assure you that the forward-looking statements in this communication will prove to be accurate. There may be additional risks that TNL Mediagene presently does not know or that TNL Mediagene currently does not believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by TNL Mediagene, its directors, officers or employees or any other person. Except as required by applicable law, TNL Mediagene does not have any duty to, and does not intend to, update or revise the forward-looking statements in this communication or elsewhere after the date of this communication. You should, therefore, not rely on these forward-looking statements as representing the views of TNL Mediagene as of any date subsequent to the date of this communication.

View original content to download multimedia:https://www.prnewswire.com/news-releases/tnl-mediagene-featured-on-mcnallie-money-interview-302461912.html

SOURCE TNL Mediagene

NEW YORK, May 21, 2025 /PRNewswire/ — SmarterDx, the leader in clinical AI for revenue integrity and care quality, has been selected by Modern Healthcare as one of the 2025 Best Places to Work in Healthcare. The complete list of this year’s winners, in alphabetical order, is available at ModernHealthcare.com/bestplaceslist. Modern Healthcare will publish a special supplement featuring a ranked list of all the winners along with the Oct. 13, 2025, issue of MH magazine.

SmarterDx builds clinical AI that helps hospitals and health systems analyze the complete record of every patient to fully capture the value of care provided. The company was founded by physicians and data scientists with an emphasis on embedding deep clinical and technical expertise into everything the company does and builds. SmarterDx has a fully remote team, which has grown over 250% year over year. This recognition reflects the intentional ways the company has shaped how it works: through flexible, remote-first policies, generous benefits, competitive pay, and intentional team gatherings that foster connection and collaboration.

“Being recognized as a 2025 Best Place to Work in Healthcare is a powerful testament to how these organizations value their people,” said Dan Peres, President of Modern Healthcare. “In a time of constant change and challenge, this year’s winners have shown a deep commitment to creating environments where employees feel supported, heard, and inspired to do their best work. That kind of culture doesn’t happen by accident — it’s intentional, and it’s worth celebrating.”

“We believe building a great company starts with hiring incredible people, and this recognition means so much because it’s based on their evaluations,” said Joshua Geleris, MD, co-founder and head of product and data science at SmarterDx. “It reflects our team’s shared vision for building clinical AI that decreases the cost of healthcare. And by putting our customers first and working together, we’re making a meaningful difference.”

This award program identifies and recognizes outstanding employers in the healthcare industry nationwide. Modern Healthcare partners with Workforce Research Group on the assessment process, which includes an extensive employee survey.

SmarterDx will find out their ranking on the Best Places list and be celebrated at the 2025 Best Places to Work in Healthcare Awards Gala taking place Oct. 8 in Nashville, TN. Information about the gala is available at ModernHealthcare.com/BestPlacesGala.

As of May 2025, SmarterDx is now part of Smarter Technologies, the automation and insights platform for healthcare efficiency. Smarter Technologies is the industry’s first AI-powered revenue management platform that helps hospitals and health systems optimize administrative workflows and strengthen financial performance.

For information or questions about the Best Places to Work in Healthcare awards program, please contact: mhawards@modernhealthcare.com

About SmarterDx
SmarterDx builds clinical AI that empowers hospitals to analyze the complete record of every patient to fully capture the value of care delivered. Founded by physicians in 2020, its proprietary AI platform understands the nuances of clinical reasoning, enabling hospitals to be true to the patient record for every discharge. By doing so, hospitals can recover millions in earned revenue, enhance care quality metrics, and optimize healthcare operations. Discover how SmarterDx is transforming healthcare at smarterdx.com.

About Smarter Technologies
Smarter Technologies, the automation and insights platform for healthcare efficiency, is a leading AI-powered revenue management platform that combines proprietary clinical agents, human-in-the-loop AI Agents, clinical ontology and global financial and administrative services that allows healthcare organizations the flexibility to automate the entirety of their administrative and financial workflows to optimize operational outcomes and drive better patient experiences. For more information, visit: www.smarter-technologies.com.

About Modern Healthcare
Modern Healthcare is the most trusted business news and information brand in the healthcare industry. Modern Healthcare empowers healthcare leaders and influencers to make timely and informed business decisions. To learn more or subscribe, go to www.modernhealthcare.com/subscriptions.

CONTACT:
Smarter Technologies
John Hallock
john.hallock@smarter-technologies.com
(617) 615-7712

SmarterDx
Marisa Johnson
marisa.johnson@smarterdx.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/smarterdx-recognized-by-modern-healthcare-as-one-of-the-best-places-to-work-in-healthcare-in-2025-302461891.html

SOURCE SmarterDx

FAIRFIELD, N.J., May 21, 2025 /PRNewswire/ — Keypoint Intelligence has released a new Market Insight Report exploring the rise of smarter, more connected multifunction printers (MFPs) and how leading technology vendors are integrating advanced capabilities into their devices. The report offers a clear look at how intelligent features are reshaping print technology, from automation and maintenance to workflow and user experience, and what truly sets apart next-generation print solutions.

As organizations increasingly demand systems that do more than just print and scan, this report defines a new category: the AI-enabled MFP. It outlines the difference between adaptive, learning-based technologies and the more basic automation tools that have long existed in the space. The report also examines how vendors are embedding intelligence across hardware, software, and services.

“This report is about providing clarity in a rapidly evolving space and helping stakeholders understand where real innovation is taking place,” said Anne Valaitis, Principal Analyst at Keypoint Intelligence. “There’s growing interest in intelligent print solutions, and our goal is to identify which developments offer genuine business value.”

Key takeaways from the report include:

Establishes clear criteria for what qualifies as a truly intelligent MFP

Distinguishes real-world applications from marketing-driven claims

Analyzes current AI developments across 16 leading print and document solution vendors

Examines AI’s role beyond hardware including workflow automation, service optimization, and embedded software

Highlights today’s limitations and maps out areas of vendor investment and innovation

Delivers expert commentary with practical recommendations for vendors and buyers

This report is a valuable resource for anyone involved in product planning, marketing, or channel strategy within the print industry. As device capabilities evolve, so do customer expectations. This report provides the insight organizations need to stay ahead.

Click here for more information or contact pr@keypointintelligence.com with questions or media inquiries.

About Keypoint Intelligence
For over 60 years, clients in the digital imaging industry have relied on Keypoint Intelligence for independent hands-on testing, lab data, and extensive market research to drive their product and sales success. Keypoint Intelligence has been recognized as the industry’s most trusted resource for unbiased information, analysis, and awards due to decades of analyst experience.

View original content to download multimedia:https://www.prnewswire.com/news-releases/keypoint-intelligence-releases-industry-first-market-insight-report-on-ai-enabled-mfps-302461317.html

SOURCE Keypoint Intelligence